Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Primovist Approved in the US: Bayer HealthCare
August 4, 2008
- TOPICS／JADEC, sanofi-aventis Cosponsor HbA1c Awareness Enhancement Campaign
August 4, 2008
- PMDA Receives Highest Rating Regarding Balance of Payment, Relief of ADR Victims
August 4, 2008
- Korosho Requires Makers of MTX to Take New Measures to Prevent Overdosing
July 28, 2008
- BUSINESS NEWS IN BRIEF
July 28, 2008
- Korosho Shows Interest in GPOs of the US
July 28, 2008
- JPLA SEMINAR
July 28, 2008
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 28, 2008
- Average Wage Hike \5,949 in 2008
July 28, 2008
- Gefitinib Beneficial for Adenocarcinoma Regardless of Smoking History
July 28, 2008
- Pfizer to Develop Market for Sutent as First-Line Therapy for RCC
July 28, 2008
- Clopidogrel May Be Less Effective in Japanese than in Westerners
July 28, 2008
- Eisai Develops Add'l Indications, Dosage Forms for Aricept as Part of Life Cycle Management
July 28, 2008
- Korosho Presents Draft Vision for Medical Devices Industry
July 28, 2008
- Kyowa Hakko, Lonza Extend Their Strategic Collaboration
July 28, 2008
- Asahi Kasei to Enter Market for Advanced Medical Devices
July 28, 2008
- Nichi-Iko Aims at Becoming World Top-10 Generic Maker
July 28, 2008
- GENERICS NEWS IN BRIEF
July 28, 2008
- Korosho Announces Drug Dispensing Fees per Prescription for the First Time
July 28, 2008
- Sawai to Focus on Drugs for Lifestyle Diseases
July 28, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…